Literature DB >> 14757692

Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction.

Chong Do Lee1, Aaron R Folsom, James S Pankow, Frederick L Brancati.   

Abstract

BACKGROUND: Whether diabetic patients without a history of myocardial infarction (MI) have the same risk of coronary heart disease (CHD) events as nondiabetic patients with a history of MI remains controversial. We compared risks of CHD and stroke events and mortality from cardiovascular disease (CVD) in diabetic and nondiabetic men and women with and without a history of MI. METHODS AND
RESULTS: We followed a total of 13 790 African American and white men and women ages 45 to 64 years who participated in the Atherosclerosis Risk in Communities study, beginning in 1987 to 1989. There were 634 fatal CHD or nonfatal MI events, 312 fatal or nonfatal strokes, and 358 deaths from CVD during an average of 9 years of follow-up (125 998 person-years). After adjustment for age, sex, race, Atherosclerosis Risk in Communities field center, and multiple baseline risk factors, patients who had a history of MI without diabetes at baseline had 1.9 times the risk of fatal CHD or nonfatal MI (95% CI, 1.35 to 2.56; P<0.001) compared with diabetic patients without a prior history of MI. The nondiabetic patients with MI also had 1.8 times the risk of CVD mortality compared with diabetic patients without MI (95% CI, 1.22 to 2.72; P=0.003). However, stroke risk was similar between diabetic patients without MI and nondiabetic patients with MI (RR, 1.05; 95% CI, 0.61 to 1.79; P=0.87). We also observed that nondiabetic patients with MI had a carotid artery wall thickness similar to diabetic patients without MI (P=0.77).
CONCLUSIONS: Diabetic patients without MI had lower risk of CHD events and mortality from CVD compared with nondiabetic patients with MI, but stroke risk was similar between these 2 groups.

Entities:  

Mesh:

Year:  2004        PMID: 14757692     DOI: 10.1161/01.CIR.0000116389.61864.DE

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

1.  Practical aspects of the control of cardiovascular risk in type 2 diabetes mellitus and the metabolic syndrome.

Authors:  Anca Cerghizan; Cornelia Bala; Cristina Nita; Nicolae Hancu
Journal:  Exp Clin Cardiol       Date:  2007

2.  Development and Validation of PREDICT-DM: A New Microsimulation Model to Project and Evaluate Complications and Treatments of Type 2 Diabetes Mellitus.

Authors:  Pooyan Kazemian; Deborah J Wexler; Naomi F Fields; Robert A Parker; Amy Zheng; Rochelle P Walensky
Journal:  Diabetes Technol Ther       Date:  2019-06       Impact factor: 6.118

3.  The effect of diabetes and stroke at baseline and during follow-up on stroke mortality.

Authors:  G Hu; P Jousilahti; C Sarti; R Antikainen; J Tuomilehto
Journal:  Diabetologia       Date:  2006-08-01       Impact factor: 10.122

4.  [Cardiac imaging in (asymptomatic) diabetic patients].

Authors:  M J Zellweger
Journal:  Herz       Date:  2012-05       Impact factor: 1.443

5.  Coronary risk equivalence of diabetes assessed by SPECT-MPI.

Authors:  Donna Chelle V Morales; Sanjeev P Bhavnani; Alan W Ahlberg; Raja C Pullatt; Deborah M Katten; Donna M Polk; Gary V Heller
Journal:  J Nucl Cardiol       Date:  2017-12-06       Impact factor: 5.952

6.  Long-term cardiovascular risk in type 2 diabetic compared with nondiabetic first acute myocardial infarction patients: a population-based cohort study in southern Europe.

Authors:  J Francisco Cano; Jose M Baena-Diez; Josep Franch; Joan Vila; Susana Tello; Joan Sala; Roberto Elosua; Jaume Marrugat
Journal:  Diabetes Care       Date:  2010-06-08       Impact factor: 19.112

7.  New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population.

Authors:  Farzad Hadaegh; Nooshin Fahimfar; Davood Khalili; Farhad Sheikholeslami; Fereidoun Azizi
Journal:  Cardiovasc Diabetol       Date:  2010-12-04       Impact factor: 9.951

Review 8.  The obesity, metabolic syndrome, and type 2 diabetes mellitus pandemic: Part I. Increased cardiovascular disease risk and the importance of atherogenic dyslipidemia in persons with the metabolic syndrome and type 2 diabetes mellitus.

Authors:  Henry N Ginsberg; Paul R MacCallum
Journal:  J Cardiometab Syndr       Date:  2009

9.  Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients.

Authors:  Giacomo Zoppini; Giovanni Targher; Carlo Negri; Vincenzo Stoico; Fabrizia Perrone; Michele Muggeo; Enzo Bonora
Journal:  Diabetes Care       Date:  2009-06-19       Impact factor: 19.112

Review 10.  Aspirin for primary prevention of cardiovascular events in people with diabetes: meta-analysis of randomised controlled trials.

Authors:  Giorgia De Berardis; Michele Sacco; Giovanni F M Strippoli; Fabio Pellegrini; Giusi Graziano; Gianni Tognoni; Antonio Nicolucci
Journal:  BMJ       Date:  2009-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.